Medical news and articles
Hear from Genea and read our latest medical breakthroughs and press releases.
Media Contact
Media Enquiries
M: 0436 489 199
News
Australia continues to strengthen its understanding of Ovarian Hyperstimulation Syndrome (OHSS), particularly in patients considered high risk during IVF treatment. A new study co-authored by Genea Fertility specialists Dr Genia Rozen and A/Prof Alex Polyakov examined cases of severe OHSS in women who received either a traditional HCG trigger or a GnRH agonist (GnRHa) trigger.
Dean Morbeck, our Chief Scientific Officer at Genea, published research exploring how blastocyst development could serve as a reliable indicator of IVF success, potentially reducing the need for lengthy clinical trials and helping accelerate approval of new fertility treatments while maintaining safety standards.
In this article, A/Prof Alex Polyakov addresses the important question of when it is safe to conceive after a miscarriage and outlines strategies for promoting a healthy subsequent pregnancy. Miscarriage can significantly impact a woman's physical and emotional health, and determining the right time to try again is crucial.
In this paper, A/Prof Alex Polyakov and Dr Genia Rozen highlight how new reproductive medicine technologies often spark initial excitement but can lead to disappointment when prematurely adopted without thorough testing. It argues that overconfidence in unproven methods, fueled by the Dunning-Kruger effect, exacerbates this cycle and risks patient safety.
Trying to conceive can bring about a mix of emotions, especially for women experiencing irregular menstrual cycles or unexplained infertility despite persistent attempts. With Genea’s precise ovulation tracking service, GPs can help alleviate some of the uncertainty associated with the conception process, providing patients with valuable insights and tools to enhance their fertility journey.
A British study found that 26% of IVF attempts with frozen eggs result in a live birth, comparable to overall IVF success rates. A/Prof Alex Polyakov, Medical Director at Genea Melbourne, explains that the age at which eggs are harvested is crucial for success, with eggs frozen before age 35 yielding higher live birth rates. He advises freezing eggs between ages 30-34 for optimal outcomes, noting that freezing eggs is now comparable to undergoing IVF immediately.
Dr Anthony Marren contributed to the first Australasian guidelines for recurrent pregnancy loss, emphasising that GPs should now offer investigations after two pregnancy losses, rather than waiting for three as per older international guidelines. These new guidelines aim to simplify the diagnostic process and provide timely support for couples experiencing recurrent pregnancy loss.
FAQs
Genea shares peer-reviewed research papers, clinical guidelines, media releases, and educational articles about fertility treatments and reproductive medicine. Our content covers topics including IVF success rates, miscarriage management, and emerging fertility technologies, authored by our specialist fertility doctors and scientists.
You can visit this Medical News and Articles page regularly to read our latest publications and press releases. For media enquiries or interview requests, contact our media team at media@genea.com.au or call 0436 489 199. We publish updates on breakthrough research, clinical guidelines, and new fertility services as they become available.
Genea's research appears in leading international medical journals including Fertility and Sterility, The Australian Journal of General Practice (AJGP), and ScienceDirect publications. Our specialists and scientists also contribute to clinical guidelines and present findings at conferences such as the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) annual meetings.
In July 2025, Genea's Chief Scientific Officer Dean Morbeck published research in Fertility and Sterility exploring how blastocyst development patterns can predict IVF success rates. This research aims to streamline the approval process for new fertility treatments while maintaining safety standards. Additionally, British studies cited by Genea specialists show that frozen eggs achieve comparable live birth rates to fresh eggs in IVF cycles.
Yes, Genea regularly publishes educational content for general practitioners, including clinical guidelines and service information. Recent publications cover topics such as optimal timing for conception after miscarriage, new protocols for investigating recurrent pregnancy loss after two losses rather than three, and bulk-billed ovulation tracking services that GPs can recommend to patients.
Genea takes an evidence-based approach to new reproductive technologies. Research published by A/Prof Alex Polyakov and Dr Genia Rozen in ScienceDirect emphasises the importance of thorough testing before adopting new fertility treatments, warning against premature implementation that could risk patient safety despite initial enthusiasm for innovations.
Genea specialists contributed to the first Australasian guidelines for recurrent pregnancy loss, which now recommend offering investigations after two pregnancy losses rather than three. Dr Anthony Marren, Dr Danielle Robson and Dr Ying Li work on these guidelines aims to provide earlier support and simplified diagnostic processes for couples experiencing recurrent miscarriage.
